TSE •
Healthcare •
Biotechnology •
Quote as of 08/25/2026 15:30
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeTSE
Market Capitalization101,153 mln
Float69.16 mln
Earnings Date10/30/2026
Piotroski F-Score
4
/ 9
Borderline
Beneish M-Score
-1.14
Manipulation likely
1-Year Forecast
1,928
Transformational upside
Relative Strength
98
/ 100
Top performer
Debt / Equity
0.88
Moderate leverage
ROE
-19.38
Negative
Business Description
Nxera Pharma is a Japanese biopharmaceutical company founded in 1990 and headquartered in Tokyo, with operations across the US, Europe, and beyond. The company specializes in discovering and developing new medicines targeting brain and nervous system conditions, including schizophrenia, insomnia, sleep disorders, and inflammatory diseases, using its proprietary drug discovery platform. Its portfolio spans several products already on the market as well as a broad pipeline of drugs at various stages of clinical testing. Nxera works alongside a number of major global pharmaceutical partners, including Pfizer, Novartis, AbbVie, and Lilly.
